{"id":"meglumine","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Contrast Media","category":"pharmacology"},{"label":"Diagnostic Uses of Chemicals","category":"pharmacology"}],"phase":"marketed","safety":{"boxedWarnings":["NOT FOR INTRATHECAL USE"],"commonSideEffects":[{"effect":"Inappetence","drugRate":"","severity":"common","organSystem":""},{"effect":"Diarrhea","drugRate":"","severity":"common","organSystem":""},{"effect":"Decreased water consumption","drugRate":"","severity":"common","organSystem":""},{"effect":"Injection site swelling","drugRate":"","severity":"common","organSystem":""}],"seriousAdverseEvents":[{"effect":"Anaphylaxis","drugRate":"","severity":"serious"},{"effect":"Collapse","drugRate":"","severity":"serious"},{"effect":"Anaphylactic-like reactions","drugRate":"","severity":"serious"},{"effect":"Fatal anaphylactic-like reactions","drugRate":"","severity":"serious"}]},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":["meglumine"],"offLabel":[],"synonyms":["meglumine"],"timeline":[],"aiSummary":"Meglumine is a small molecule compound originally developed by an unknown entity. Its current owner is also unknown. The target and drug class of Meglumine are not specified. It is not known whether Meglumine is FDA approved or has any approved indications. The commercial status of Meglumine, including whether it is patented or generic, is also unknown.","approvals":[{"date":"","orphan":false,"company":"","regulator":"FDA"}],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"Meglumine is a compound that works by acting as a stabilizer or carrier for other medications, helping them to be more effective and stable in the body. It does not have a direct therapeutic effect on its own, but rather supports the action of other drugs. This can make it easier for patients to take their medications and for healthcare providers to administer them.","oneSentence":"Meglumine is a compound that works by","technicalDetail":"Meglumine is a small molecule compound that functions as a stabilizer or carrier for other medications, potentially through interactions with biological membranes or protein binding sites, although specific mechanisms are not well established."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/5194","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://clinicaltrials.gov/search?intr=MEGLUMINE","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":3,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=MEGLUMINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T12:33:23.077537","biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"genericName":"meglumine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT03730051","phase":"PHASE4","title":"Dotarem vs Gadobutrol Contrast for Breast MRI","status":"COMPLETED","sponsor":"University of Massachusetts, Worcester","startDate":"2021-03-01","conditions":["Breast Diseases"],"enrollment":300,"completionDate":"2025-12-31"},{"nctId":"NCT07251712","phase":"PHASE1","title":"Single and Multiple Dose Pharmacokinetics (PK) of Aramchol From an Aramchol Meglumine Tablet","status":"RECRUITING","sponsor":"Galmed Pharmaceuticals Ltd","startDate":"2025-12-25","conditions":["Healthy"],"enrollment":32,"completionDate":"2026-05-15"},{"nctId":"NCT06057168","phase":"PHASE3","title":"Performance of Elucirem in DSC-MRI Perfusion of Brain Gliomas","status":"COMPLETED","sponsor":"Guerbet","startDate":"2023-09-07","conditions":["Brain Tumor, Primary","Brain Tumor, Recurrent"],"enrollment":138,"completionDate":"2024-11-28"},{"nctId":"NCT04373564","phase":"PHASE4","title":"Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years","status":"RECRUITING","sponsor":"Guerbet","startDate":"2021-03-24","conditions":["Motor Function","Cognitive Function","Contrast Media"],"enrollment":2076,"completionDate":"2028-12-31"},{"nctId":"NCT07348640","phase":"PHASE3","title":"Evaluation of the Efficacy and Safety of Magnetic Resonance Angiography (MRA) Using Gadopiclenol Compared to Gadoterate Meglumine in the Assessment of Steno-occlusive Disease in Adult Patients With Suspected Vascular Disease","status":"NOT_YET_RECRUITING","sponsor":"Guerbet","startDate":"2026-02-02","conditions":["Steno-occlusive Disease"],"enrollment":315,"completionDate":"2027-12-31"},{"nctId":"NCT02973633","phase":"EARLY_PHASE1","title":"Diffusion MRI in Heart Failure","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2017-06-30","conditions":["Heart Failure","Myocardial Infarction","Left Ventricular Hypertrophy"],"enrollment":160,"completionDate":"2028-12-31"},{"nctId":"NCT05915728","phase":"PHASE3","title":"A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)","status":"COMPLETED","sponsor":"Bayer","startDate":"2023-07-24","conditions":["Contrast Enhancement in Magnetic Resonance Imaging","Non-central Nervous System Pathology"],"enrollment":404,"completionDate":"2024-06-01"},{"nctId":"NCT06502561","phase":"PHASE1","title":"Comparing The PK Of Aramchol Meglumine Granules To Aramchol Free Acid Tablets","status":"ACTIVE_NOT_RECRUITING","sponsor":"Galmed Pharmaceuticals Ltd","startDate":"2025-02-15","conditions":["Healthy"],"enrollment":16,"completionDate":"2025-12"},{"nctId":"NCT05937776","phase":"","title":"Developing a New Metabolic Imaging Approach (aMRI) for Evaluating Neurological Disease in Patients With Gliomas","status":"RECRUITING","sponsor":"OHSU Knight Cancer Institute","startDate":"2023-12-11","conditions":["Glioma"],"enrollment":20,"completionDate":"2025-12-31"},{"nctId":"NCT05915702","phase":"PHASE3","title":"A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Known or Suspected Brain or Spinal Cord-related Problems","status":"COMPLETED","sponsor":"Bayer","startDate":"2023-07-24","conditions":["Contrast Enhancement in Magnetic Resonance Imaging","Central Nervous System Pathology"],"enrollment":303,"completionDate":"2024-05-31"},{"nctId":"NCT02382380","phase":"PHASE4","title":"Evaluation of Gadoterate in Patients With Renal Dysfunction","status":"TERMINATED","sponsor":"Loyola University","startDate":"2014-11-05","conditions":["Renal Dysfunction"],"enrollment":46,"completionDate":"2024-03-20"},{"nctId":"NCT06940336","phase":"PHASE4","title":"To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy","status":"RECRUITING","sponsor":"Qilu Pharmaceutical Co., Ltd.","startDate":"2025-06-19","conditions":["Transthyretin Amyloid Polyneuropathy"],"enrollment":15,"completionDate":"2028-02"},{"nctId":"NCT06754956","phase":"NA","title":"Imaging of Intracranial and Extracranial Arterial Atherosclerotic Plaques Using Different Field Strength MRIs","status":"RECRUITING","sponsor":"Shanghai Jiao Tong University Affiliated Sixth People's Hospital","startDate":"2025-01-10","conditions":["High Resolution Vessel Wall Imaging","Intracranial Atherosclerotic Stenosis, ICAS","Arteriosclerosis"],"enrollment":100,"completionDate":"2027-12-23"},{"nctId":"NCT06095986","phase":"PHASE2","title":"A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis","status":"WITHDRAWN","sponsor":"Galmed Pharmaceuticals Ltd","startDate":"2025-06","conditions":["Primary Sclerosing Cholangitis"],"enrollment":0,"completionDate":"2027-12"},{"nctId":"NCT06600880","phase":"PHASE1","title":"Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau","status":"NOT_YET_RECRUITING","sponsor":"Columbia University","startDate":"2026-08","conditions":["Alzheimer Disease, Early Onset"],"enrollment":6,"completionDate":"2027-12"},{"nctId":"NCT05417776","phase":"PHASE2","title":"Collagen-targeted PET Imaging for Early Interstitial Lung Disease","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2022-09-28","conditions":["Interstitial Lung Disease"],"enrollment":30,"completionDate":"2026-04-01"},{"nctId":"NCT04268524","phase":"PHASE3","title":"Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan","status":"RECRUITING","sponsor":"Medecins Sans Frontieres, Netherlands","startDate":"2022-10-07","conditions":["Old World Cutaneous Leishmaniasis"],"enrollment":832,"completionDate":"2026-01-31"},{"nctId":"NCT04515186","phase":"PHASE3","title":"Combination, Miltefosine Monotherapy for Cutaneous Leishmaniasis in New World","status":"COMPLETED","sponsor":"Drugs for Neglected Diseases","startDate":"2021-01-26","conditions":["Cutaneous Leishmaniases"],"enrollment":184,"completionDate":"2024-02-27"},{"nctId":"NCT04108091","phase":"","title":"Vyndaqel Capsules Special Investigation (ATTR-CM)","status":"COMPLETED","sponsor":"Pfizer","startDate":"2019-10-03","conditions":["Transthyretin (TTR) Amyloid Cardiomyopathy"],"enrollment":1214,"completionDate":"2025-03-27"},{"nctId":"NCT06183242","phase":"PHASE2,PHASE3","title":"Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2023-05-27","conditions":["Cholestasis, Intrahepatic"],"enrollment":328,"completionDate":"2024-10-10"},{"nctId":"NCT06183229","phase":"PHASE3","title":"Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2023-09-15","conditions":["Influenza","Acute Respiratory Infection"],"enrollment":166,"completionDate":"2024-06-10"},{"nctId":"NCT06267807","phase":"NA","title":"Lymphatic Phenotype in Noonan Syndrome Spectrum Disorders","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2024-03-27","conditions":["Lymphatic System Disorders Congenital","Lymphatic Diseases","Noonan Syndrome","Lymphatic Disease"],"enrollment":9,"completionDate":"2025-04-01"},{"nctId":"NCT05928286","phase":"","title":"Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice","status":"RECRUITING","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2022-12-01","conditions":["Gallstone Disease","Obstructive Jaundice"],"enrollment":286,"completionDate":"2025-12"},{"nctId":"NCT06532071","phase":"PHASE2","title":"Advanced Imaging for Pulmonary Fibrosis","status":"RECRUITING","sponsor":"Peter Caravan","startDate":"2025-01-21","conditions":["Pulmonary Fibrosis"],"enrollment":60,"completionDate":"2028-12-31"},{"nctId":"NCT06861426","phase":"","title":"Effectiveness of Ginkgo Diterpene Lactone Meglumine in Acute Ischemic Stroke","status":"NOT_YET_RECRUITING","sponsor":"Ying Gao","startDate":"2025-03-01","conditions":["Acute Ischemic Stroke"],"enrollment":4460,"completionDate":"2025-12-31"},{"nctId":"NCT06822478","phase":"PHASE3","title":"Arnica Tincture Fot the Treatment of Cutaneous Leishmaniasis II.","status":"NOT_YET_RECRUITING","sponsor":"Universidad de Antioquia","startDate":"2025-10","conditions":["Leishmaniasis, Cutaneous"],"enrollment":96,"completionDate":"2029-02"},{"nctId":"NCT02791230","phase":"PHASE3","title":"Long-term Safety of Tafamidis in Subjects With Transthyretin Cardiomyopathy","status":"COMPLETED","sponsor":"Pfizer","startDate":"2016-06-13","conditions":["Transthyretin (TTR) Amyloid Cardiomyopathy"],"enrollment":1733,"completionDate":"2023-11-02"},{"nctId":"NCT05172180","phase":"","title":"Correction of Metabolic Disorders and Its Effect on Respiratory Function of Lungs in Patients With Severe COVID-19","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2020-12-01","conditions":["COVID-19"],"enrollment":105,"completionDate":"2021-04-01"},{"nctId":"NCT03337594","phase":"","title":"Gadolinium Retention in Human Bone Tissue in Pediatric Patients","status":"COMPLETED","sponsor":"Donna Roberts","startDate":"2017-10-01","conditions":["Gadolinium","MultiHance","Dotarem","Magnetic Resonance Imaging","Gadolinium Retention"],"enrollment":57,"completionDate":"2024-08-31"},{"nctId":"NCT03937921","phase":"","title":"Dotarem Evaluation for Myocardial Perfusion CMR","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2019-07-03","conditions":["Myocardial Perfusion Imaging","Magnetic Resonance Imaging"],"enrollment":90,"completionDate":"2024-10-31"},{"nctId":"NCT06433791","phase":"PHASE1","title":"Evaluation of Ascorbate-Meglumine Therapeutic for SRS","status":"ENROLLING_BY_INVITATION","sponsor":"LadeRx LLC","startDate":"2024-09-09","conditions":["Safety"],"enrollment":12,"completionDate":"2025-09-09"},{"nctId":"NCT06101719","phase":"","title":"Use of a Water Soluble Contrast-Based Protocol to Assist in the Management of Pediatric Adhesive Small Bowel Obstruction","status":"COMPLETED","sponsor":"Children's Hospital Colorado","startDate":"2020-10-01","conditions":["Small Bowel Obstruction","Contrast Media Adverse Reaction"],"enrollment":136,"completionDate":"2023-12-31"},{"nctId":"NCT04480827","phase":"PHASE1","title":"Open-Label Study to Evaluate the Safety, Tolerability, and PK of Aramchol in Subjects With Hepatic Impairment","status":"COMPLETED","sponsor":"Galmed Research and Development, Ltd.","startDate":"2020-02-13","conditions":["Hepatic Impairment"],"enrollment":57,"completionDate":"2022-03-24"},{"nctId":"NCT01514617","phase":"NA","title":"Diffusion -and Perfusion Weighted MRI for Response Prediction of Symptomatic Leiomyomas Following Uterine Artery Embolization","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2012-01","conditions":["Leiomyomas"],"enrollment":100,"completionDate":"2025-12"},{"nctId":"NCT05498701","phase":"PHASE1","title":"A Study Comparing Two Forms of Tafamidis Without Food and the Amount of Tafamidis in the Blood With Food","status":"COMPLETED","sponsor":"Pfizer","startDate":"2022-09-29","conditions":["Healthy"],"enrollment":22,"completionDate":"2022-12-19"},{"nctId":"NCT06182319","phase":"PHASE3","title":"Optimizing Treatment of Adhesive Small Bowel Obstruction","status":"RECRUITING","sponsor":"University of California, Los Angeles","startDate":"2024-01-01","conditions":["Adhesive Small Bowel Obstruction"],"enrollment":40,"completionDate":"2025-12-15"},{"nctId":"NCT04828993","phase":"PHASE4","title":"The Effect Of Tafamidis Meglumine In Transthyretin Amyloid Polyneuropathy Patients","status":"COMPLETED","sponsor":"Pfizer","startDate":"2021-04-28","conditions":["Transthyretin Amyloid Polyneuropathy (ATTR-PN)"],"enrollment":15,"completionDate":"2023-02-12"},{"nctId":"NCT04799236","phase":"PHASE3","title":"Treatment of Mucosal Bolivian Leishmaniasis","status":"RECRUITING","sponsor":"Fundacion Nacional de Dermatologia","startDate":"2021-04-01","conditions":["Mucosal Leishmaniasis"],"enrollment":120,"completionDate":"2024-11-30"},{"nctId":"NCT02344654","phase":"NA","title":"Fluorescence Cholangiography During Cholecystectomy - a RCT","status":"COMPLETED","sponsor":"Hvidovre University Hospital","startDate":"2015-05-01","conditions":["Cholecystitis","Gallstones"],"enrollment":120,"completionDate":"2018-08-27"},{"nctId":"NCT05726097","phase":"PHASE3","title":"Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure","status":"COMPLETED","sponsor":"Region Skane","startDate":"2023-02-01","conditions":["Colon Cancer","Inflammatory Bowel Diseases","Gastrointestinal Bleed","Colon Polyp"],"enrollment":147,"completionDate":"2023-10-31"},{"nctId":"NCT02530697","phase":"PHASE2","title":"The Association of Miltefosine and Pentoxifylline to Treat Mucosal and Cutaneous Leishmaniasis: A Clinical Trial in Brazil","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Brasilia","startDate":"2015-08","conditions":["Leishmaniasis"],"enrollment":160,"completionDate":"2026-08"},{"nctId":"NCT04341129","phase":"EARLY_PHASE1","title":"Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2020-07-13","conditions":["Breast Neoplasms","Breast Diseases","Breast Fibroadenoma","Breast Cancer"],"enrollment":50,"completionDate":"2023-06-30"},{"nctId":"NCT03573921","phase":"PHASE2,PHASE3","title":"Gastrografin for Treating Small Bowel Obstruction in Children","status":"TERMINATED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2019-09-01","conditions":["Small Bowel Obstruction"],"enrollment":2,"completionDate":"2022-12-19"},{"nctId":"NCT03334578","phase":"PHASE4","title":"The Use of Gastrografin to Help Alleviate Bowel Obstruction in Gastroschisis Patients.","status":"WITHDRAWN","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2018-08-03","conditions":["Gastroschisis","Bowel Obstruction","Birth Defect"],"enrollment":0,"completionDate":"2020-12-17"},{"nctId":"NCT06011343","phase":"PHASE2,PHASE3","title":"Tofacitinib Associated With Meglumine Antimoniate in Cutaneous Leishmaniasis","status":"UNKNOWN","sponsor":"Hospital Universitário Professor Edgard Santos","startDate":"2023-10-01","conditions":["Cutaneous Leishmaniasis, American"],"enrollment":22,"completionDate":"2025-07-01"},{"nctId":"NCT06000514","phase":"PHASE1,PHASE2","title":"Topical Sm29 in Combination With Meglumine Antimoniate in the Treatment of Cutaneous Leishmaniasis.","status":"COMPLETED","sponsor":"Hospital Universitário Professor Edgard Santos","startDate":"2019-01-17","conditions":["Cutaneous Leishmaniasis, American"],"enrollment":20,"completionDate":"2022-07-07"},{"nctId":"NCT05531942","phase":"PHASE2,PHASE3","title":"Antiplatelet Effect of Ginkgo Diterpene Lactone Meglumine Injection in Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2021-01-01","conditions":["Ischemic Stroke"],"enrollment":70,"completionDate":"2023-11-01"},{"nctId":"NCT05786846","phase":"","title":"Serum Thyroid Function After Iodinated Contrast Administration","status":"UNKNOWN","sponsor":"Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University","startDate":"2023-02-15","conditions":["Thyroid Dysfunction"],"enrollment":400,"completionDate":"2023-12-01"},{"nctId":"NCT02526225","phase":"PHASE2","title":"A Safety and Effective Study of Ginkgolides Diterpene Lactone Meglumine Injection in the Treatment of Ischemic Stroke.","status":"COMPLETED","sponsor":"Beijing Tiantan Hospital","startDate":"2016-02-01","conditions":["Ischemic Stroke"],"enrollment":3452,"completionDate":"2019-08-31"},{"nctId":"NCT03849664","phase":"PHASE3","title":"Efficacy and Safety of Cytoflavin® Used in Elderly Patients for the Prevention of Cognitive Decline After Major Surgery","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2017-06-02","conditions":["Cognitive Dysfunction"],"enrollment":200,"completionDate":"2019-07-11"},{"nctId":"NCT05663307","phase":"PHASE2,PHASE3","title":"The Effect of Ginkgolide on Clinical Improvement of Patients With Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"Shanghai Yueyang Integrated Medicine Hospital","startDate":"2021-01-01","conditions":["Ischemic Stroke, Acute"],"enrollment":80,"completionDate":"2023-12-01"},{"nctId":"NCT05147051","phase":"PHASE2","title":"Meglimine Sodium Succinate for Correction of Metabolic Acidosis in Critically Ill Patients","status":"COMPLETED","sponsor":"POLYSAN Scientific & Technological Pharmaceutical Company","startDate":"2021-06-16","conditions":["Metabolic Acidosis"],"enrollment":140,"completionDate":"2022-06-22"},{"nctId":"NCT05523648","phase":"EARLY_PHASE1","title":"Clinical Effects of Ganshuang Combined TDF to Treat CHB and NAFLD","status":"COMPLETED","sponsor":"Sichuan Leshan Traditional Chinese Medicine Hospital","startDate":"2020-01-05","conditions":["Chronic Hepatitis B","Nonalcoholic Fatty Liver Disease"],"enrollment":92,"completionDate":"2021-12-21"},{"nctId":"NCT05493059","phase":"","title":"Study of Cases of Cutaneous Leishmaniasis Treated With Miltefosine in French Guiana, Retrospective Study","status":"UNKNOWN","sponsor":"Centre Hospitalier de Cayenne","startDate":"2022-08-08","conditions":["Cutaneous Leishmaniases","Treatment Adherence","Primary Health Care","Drug Evaluation"],"enrollment":20,"completionDate":"2022-10-08"},{"nctId":"NCT03023566","phase":"","title":"Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI","status":"COMPLETED","sponsor":"Phoenix Children's Hospital","startDate":"2017-02-09","conditions":["Brain Diseases"],"enrollment":250,"completionDate":"2017-11-12"},{"nctId":"NCT05199792","phase":"","title":"Efficacy of Gadoterate Meglumine in Diagnosis of Vascular Diseases Using MRA MRA","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2017-06-02","conditions":["Vascular Diseases"],"enrollment":65,"completionDate":"2020-01-01"},{"nctId":"NCT05169450","phase":"NA","title":"Efficacy of Diterpene Ginkgolides Meglumine Injection in Elderly Patients With Ischemic Stroke","status":"COMPLETED","sponsor":"Dongzhimen Hospital, Beijing","startDate":"2013-07-01","conditions":["Stroke","Ischemic Stroke","Nervous System Diseases","Cerebral Infarction","Brain Ischemia","Brain Infarction"],"enrollment":998,"completionDate":"2014-04-01"},{"nctId":"NCT04963985","phase":"PHASE4","title":"The Effect of Tafamidis on Transthyretin Stabilization, Safety, Tolerability and Efficacy in Transthyretin Amyloid Polyneuropathy Patients","status":"UNKNOWN","sponsor":"Peking University Third Hospital","startDate":"2021-06-01","conditions":["Transthyretin Amyloidosis"],"enrollment":10,"completionDate":"2023-06-01"},{"nctId":"NCT03602339","phase":"PHASE4","title":"Comparison of Gadovist 75% Standard Dose to Dotarem at Full Standard Dose","status":"COMPLETED","sponsor":"Bayer","startDate":"2018-11-14","conditions":["Magnetic Resonance Imaging"],"enrollment":157,"completionDate":"2020-05-26"},{"nctId":"NCT02163005","phase":"PHASE4","title":"A Feasibility Study to Assess the Use of Gadolinium in Computed Tomography","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2016-12","conditions":["Contrast Media Allergy"],"enrollment":0,"completionDate":"2018-12"},{"nctId":"NCT03091803","phase":"","title":"QSM and Regional DCE MRI Permeability Using GOCART Technique","status":"WITHDRAWN","sponsor":"University of Southern California","startDate":"2017-04-04","conditions":["Intracranial Neoplasm"],"enrollment":0,"completionDate":"2021-04-04"},{"nctId":"NCT04575116","phase":"PHASE1","title":"A Study to Determine the Bioequivalence of Two Doses of Tafamidis","status":"COMPLETED","sponsor":"Pfizer","startDate":"2020-09-17","conditions":["Healthy"],"enrollment":23,"completionDate":"2021-02-23"},{"nctId":"NCT04776187","phase":"PHASE4","title":"Safety Evaluation of Linear and Macrocyclic Gadolinium Based Contrast Agents for Patients With Mild to Moderate Renal Insufficiency Undergoing Enhanced Magnetic Resonance Imaging","status":"UNKNOWN","sponsor":"The Central Hospital of Lishui City","startDate":"2021-03-01","conditions":["Nephrogenic Fibrosing Dermopathy"],"enrollment":600,"completionDate":"2021-12-31"},{"nctId":"NCT02598674","phase":"","title":"Severe Sepsis in Children - IMPRESS-C","status":"WITHDRAWN","sponsor":"University of Florida","startDate":"2019-10","conditions":["Acute Kidney Injury","Chronic Kidney Disease","Hypertension"],"enrollment":0,"completionDate":"2021-09"},{"nctId":"NCT02783768","phase":"EARLY_PHASE1","title":"Ventilation and Pulmonary Endothelium Toxicities of E-cigarettes: A Randomized Crossover Pilot Study","status":"COMPLETED","sponsor":"Columbia University","startDate":"2017-03-01","conditions":["Pulmonary Disease, Chronic Obstructive","E-cigarettes"],"enrollment":12,"completionDate":"2018-07-24"},{"nctId":"NCT04340128","phase":"PHASE3","title":"Efficacy of Intra-lesional Injections of Glucantime Once a Week or Twice a Week in the Treatment of Anthroponotic Cutaneous Leishmaniasis (ACL)","status":"COMPLETED","sponsor":"Tehran University of Medical Sciences","startDate":"2007-05","conditions":["Cutaneous Leishmaniasis"],"enrollment":0,"completionDate":"2007-12"},{"nctId":"NCT03023111","phase":"PHASE3","title":"Miltefosine and GM-CSF in Cutaneous Leishmaniasis","status":"COMPLETED","sponsor":"Hospital Universitário Professor Edgard Santos","startDate":"2017-06-30","conditions":["Cutaneous Leishmaniasis"],"enrollment":300,"completionDate":"2020-02-14"},{"nctId":"NCT03084952","phase":"PHASE2","title":"Phase 2 Trial to Evaluate 18-Methoxycoronaridine Efficacy, Safety and Tolerability in Cutaneous Leishmaniasis Patients","status":"UNKNOWN","sponsor":"Infan Industria Quimica Farmaceutica Nacional","startDate":"2021-05","conditions":["Leishmaniasis; American, Cutaneous","Drug Side Effect"],"enrollment":52,"completionDate":"2024-07"},{"nctId":"NCT02234375","phase":"PHASE4","title":"Use of Gadolinium in CT Pulmonary Angiography","status":"WITHDRAWN","sponsor":"Massachusetts General Hospital","startDate":"2017-07","conditions":["Pulmonary Embolism"],"enrollment":0,"completionDate":"2019-12"},{"nctId":"NCT02899377","phase":"NA","title":"A PH I Pilot Imaging Study to Evaluate Molecular Imaging Methods in HVs and pSS Pts","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2016-11-18","conditions":["Autoimmune Diseases"],"enrollment":25,"completionDate":"2018-07-12"},{"nctId":"NCT04129606","phase":"NA","title":"Bladder Perforation Post-TURBT: Definition, Incidence and Natural HistoryStudy","status":"UNKNOWN","sponsor":"Abdelwahab Hashem","startDate":"2019-07-01","conditions":["Bladder Cancer","Bladder Urothelial Carcinoma","Trauma","Injuries","Perforation of Bladder","Recurrence Tumor","Resection Margin","Seeding, Neoplasm"],"enrollment":300,"completionDate":"2021-07-01"},{"nctId":"NCT02609919","phase":"","title":"Assessment of Immediate Adverse Reactions From Dotarem in Children Under 2 Years of Age","status":"COMPLETED","sponsor":"St. Louis University","startDate":"2016-01","conditions":["Adverse Reaction to Drug","Allergic Reaction to Contrast Media"],"enrollment":150,"completionDate":"2019-07-19"},{"nctId":"NCT01806740","phase":"PHASE4","title":"DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC","status":"TERMINATED","sponsor":"Guerbet","startDate":"2013-05-09","conditions":["Hepatocellular Carcinoma"],"enrollment":37,"completionDate":"2015-10-12"},{"nctId":"NCT01254552","phase":"PHASE4","title":"Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis","status":"COMPLETED","sponsor":"Guerbet","startDate":"2010-08","conditions":["Type 2 Diabetes Mellitus","Coronary Atherosclerosis"],"enrollment":351,"completionDate":"2016-10"},{"nctId":"NCT01994889","phase":"PHASE3","title":"Safety and Efficacy of Tafamidis in Patients With Transthyretin Cardiomyopathy","status":"COMPLETED","sponsor":"Pfizer","startDate":"2013-12-09","conditions":["Transthyretin (TTR) Amyloid Cardiomyopathy"],"enrollment":441,"completionDate":"2018-02-07"},{"nctId":"NCT01211873","phase":"PHASE3","title":"Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions","status":"COMPLETED","sponsor":"Guerbet","startDate":"2010-09","conditions":["Diagnostic Self Evaluation","Central Nervous System Diseases"],"enrollment":416,"completionDate":"2011-11"},{"nctId":"NCT03910114","phase":"","title":"Gadolinium-Based-Contrast-Agents (GBCA) Enhancement During MR Urography","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"1990-07-01","conditions":["Magnetic Resonance Imaging Contrast Agents"],"enrollment":500,"completionDate":"2019-04-01"},{"nctId":"NCT03662191","phase":"PHASE1","title":"Phase I Safety, Pharmacokinetics and Bioavailability Study Comparing Rate and Extent of Absorption of Two Different Forms of Tafamidis (PF-6291826)","status":"COMPLETED","sponsor":"Pfizer","startDate":"2018-09-28","conditions":["Healthy Volunteers"],"enrollment":9,"completionDate":"2019-01-10"},{"nctId":"NCT03057561","phase":"NA","title":"Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance","status":"UNKNOWN","sponsor":"Dipan Shah","startDate":"2016-10-01","conditions":["Coronary Artery Disease","Cardiomyopathy"],"enrollment":120,"completionDate":"2021-06-30"},{"nctId":"NCT00471705","phase":"PHASE3","title":"Efficacy and Safety of Miltefosine or Thermotherapy for Cutaneous Leishmaniasis in Colombia.","status":"COMPLETED","sponsor":"Universidad de Antioquia","startDate":"2006-06","conditions":["Cutaneous Leishmaniasis"],"enrollment":437,"completionDate":"2009-12"},{"nctId":"NCT03642288","phase":"NA","title":"The Use of Gastrografin in Chronic Radiation Enteropathy With Small Bowel Obstruction","status":"UNKNOWN","sponsor":"Jinling Hospital, China","startDate":"2014-04-01","conditions":["CRE-induced SBO"],"enrollment":112,"completionDate":"2018-12-31"},{"nctId":"NCT01301937","phase":"PHASE2,PHASE3","title":"Low Antimonial Dosage in American Mucosal Leishmaniasis","status":"UNKNOWN","sponsor":"Oswaldo Cruz Foundation","startDate":"2008-10","conditions":["Mucosal Leishmaniasis","Mucocutaneous Leishmaniasis"],"enrollment":76,"completionDate":"2021-12"},{"nctId":"NCT02286258","phase":"PHASE1,PHASE2","title":"Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR)","status":"TERMINATED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2014-10","conditions":["Renal Insufficiency, Chronic","Kidney Diseases"],"enrollment":166,"completionDate":"2017-02"},{"nctId":"NCT01301924","phase":"PHASE2,PHASE3","title":"Comparison of Standard and Alternative Antimonial Dosage in Patients With American Cutaneous Leishmaniasis","status":"COMPLETED","sponsor":"Oswaldo Cruz Foundation","startDate":"2008-10","conditions":["Cutaneous Leishmaniasis"],"enrollment":72,"completionDate":"2017-12"},{"nctId":"NCT03266705","phase":"PHASE1","title":"A Study Comparing Amounts of 2 Different Forms of Tafamidis (PF-6291826) in the Blood","status":"COMPLETED","sponsor":"Pfizer","startDate":"2017-09-20","conditions":["Healthy"],"enrollment":30,"completionDate":"2018-03-01"},{"nctId":"NCT03280173","phase":"PHASE1","title":"A Study Comparing the Amounts of 2 Different Forms of Tafamidis (PF06291826), Both With and Without Food, In the Blood","status":"COMPLETED","sponsor":"Pfizer","startDate":"2017-09-29","conditions":["Healthy"],"enrollment":18,"completionDate":"2018-02-23"},{"nctId":"NCT02746926","phase":"PHASE1","title":"A Study Comparing Amounts of Tafamidis (PF-06291826) in the Blood Without Food in Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer","startDate":"2016-04-29","conditions":["Healthy"],"enrollment":12,"completionDate":"2016-07-15"},{"nctId":"NCT03294161","phase":"PHASE2","title":"Fourth-generation Immucillin Derivative DI4G Associated Therapy in Cutaneous Leishmaniasis","status":"COMPLETED","sponsor":"Hospital Universitário Professor Edgard Santos","startDate":"2014-12","conditions":["Leishmaniasis","Leishmaniasis, Cutaneous","Leishmaniasis; American"],"enrollment":50,"completionDate":"2017-06"},{"nctId":"NCT01310738","phase":"PHASE4","title":"Efficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in Brazil","status":"TERMINATED","sponsor":"University of Brasilia","startDate":"2011-02","conditions":["Visceral Leishmaniasis"],"enrollment":378,"completionDate":"2015-02"},{"nctId":"NCT01032187","phase":"PHASE4","title":"Amphotericin B to Treat Visceral Leishmaniasis in Brazilian Children","status":"COMPLETED","sponsor":"University of Brasilia","startDate":"2007-10","conditions":["Visceral Leishmaniasis"],"enrollment":101,"completionDate":"2010-07"},{"nctId":"NCT02697864","phase":"PHASE1","title":"A Study Comparing Amounts of Tafamidis In The Blood Without Food","status":"COMPLETED","sponsor":"Pfizer","startDate":"2016-04","conditions":["Healthy"],"enrollment":12,"completionDate":"2016-06"},{"nctId":"NCT03219645","phase":"PHASE2,PHASE3","title":"Ginkgo Diterpene Lactone Meglumine Injection on Platelet Reactivity in Acute Ischemic Stroke","status":"UNKNOWN","sponsor":"RenJi Hospital","startDate":"2017-07-15","conditions":["Ischemic Stroke"],"enrollment":40,"completionDate":"2017-12-31"},{"nctId":"NCT03048006","phase":"","title":"Post-marketing Surveillance Study for Evaluation of Dotarem Safety","status":"COMPLETED","sponsor":"Guerbet","startDate":"2011-01","conditions":["Contrast-enhanced MRI With Dotarem"],"enrollment":44456,"completionDate":"2013-12"},{"nctId":"NCT03041298","phase":"","title":"Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography","status":"COMPLETED","sponsor":"Guerbet","startDate":"2011-09","conditions":["MR Mammography With Dotarem"],"enrollment":1537,"completionDate":"2013-12"},{"nctId":"NCT00478556","phase":"PHASE4","title":"Omnipaque Versus Gastroview as Oral Contrast for Abdominal and Pelvic CT","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2007-08","conditions":["Healthy"],"enrollment":300,"completionDate":"2009-03"},{"nctId":"NCT02431598","phase":"PHASE4","title":"Eovist vs. Dotarem Healthy Volunteer MRI","status":"COMPLETED","sponsor":"Duke University","startDate":"2015-06","conditions":["Transient Severe Arterial Phase Motion"],"enrollment":44,"completionDate":"2015-09"},{"nctId":"NCT02967380","phase":"NA","title":"Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain Metastases","status":"TERMINATED","sponsor":"University of Southern California","startDate":"2011-12-14","conditions":["Adult Anaplastic (Malignant) Meningioma","Adult Anaplastic Astrocytoma","Adult Anaplastic Ependymoma","Adult Anaplastic Oligodendroglioma","Adult Brain Stem Glioma","Adult Choroid Plexus Neoplasm","Adult Diffuse Astrocytoma","Adult Ependymoblastoma","Adult Ependymoma","Adult Giant Cell Glioblastoma","Adult Glioblastoma","Adult Gliosarcoma","Adult Grade II Meningioma","Adult Medulloblastoma","Adult Mixed Glioma","Adult Oligodendroglioma","Adult Papillary Meningioma","Adult Pineal Gland Astrocytoma","Adult Pineoblastoma","Adult Primary Melanocytic Lesion of Meninges","Adult Supratentorial Primitive Neuroectodermal Tumor","Malignant Adult Intracranial Hemangiopericytoma","Metastatic Malignant Neoplasm in the Brain","Multiple Sclerosis","Recurrent Adult Brain Neoplasm"],"enrollment":14,"completionDate":"2015-10-14"},{"nctId":"NCT02411201","phase":"PHASE4","title":"DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years","status":"COMPLETED","sponsor":"Guerbet","startDate":"2015-03","conditions":["Magnetic Resonance Imaging"],"enrollment":51,"completionDate":"2015-10"},{"nctId":"NCT02481219","phase":"NA","title":"Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure","status":"COMPLETED","sponsor":"Medtronic - MITG","startDate":"2015-05","conditions":["Colorectal Cancer Screening"],"enrollment":122,"completionDate":"2016-02"},{"nctId":"NCT01381055","phase":"PHASE2,PHASE3","title":"Antimony Plus Pentoxifylline in Cutaneous Leishmaniasis","status":"COMPLETED","sponsor":"Paulo Roberto Lima Machado","startDate":"2012-03","conditions":["Cutaneous Leishmaniasis"],"enrollment":164,"completionDate":"2015-10"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"crossReferences":{"MMSL":"NOCODE","NDDF":"010198","UNII":"6HG8UB2MUY","CHEBI":"CHEBI:59732","VANDF":"4019579","INN_ID":"4205","RXNORM":"6704","UMLSCUI":"C0025179","ChEMBL_ID":"CHEMBL1200570","KEGG_DRUG":"D01796","DRUGBANK_ID":"DB09415","PUBCHEM_CID":"8567","MESH_DESCRIPTOR_UI":"D008536"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":3252,"therapeuticAreas":["Other"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","brandName":"MEGLUMINE","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"1982","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":"","brand_name_local":null,"application_number":""},{"country_code":"CA","regulator":"Health Canada","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":false,"safety":true,"trials":true,"score":3}}